Regenerative Innovation Target academic medical centers and research institutions, highlighting McGowan Institute's focus on tissue and organ regeneration, synthetic constructs, biohybrid organs, and cellular therapies as a gateway to partnerships in translational research, clinical trials infrastructure, and sponsored research.

Clinical Translation Pathways Position opportunities around technology transfer, contract research, and translational development programs that accelerate bringing regenerative therapies from labs to patients, leveraging their experience at the intersection of biology, engineering and clinical science.

Strategic Partnerships Leverage potential collaborations with hospitals, biotech startups, and industry sponsors seeking advanced regenerative platforms, scaffolding solutions, and cell-based therapeutics, offering co-development, funding, and access to specialized facilities.

Technology Stack Fit Offer services and tools that align with their data and design needs, such as analytics for experimental optimization, digital collaboration for multi-disciplinary teams, and scalable project management and security solutions suitable for academic research environments.

Funding & Visibility Highlight opportunities around grant support, industry-funded projects, and visibility through Pitt’s rising national ranking and collaboration initiatives, framing partnerships as ways to enhance research impact, grant success, and external funding opportunities.